| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/20/2004 | US20040096426 Compositions and methods for identifying antigens which elicit an immune response |
| 05/20/2004 | US20040096425 Method for introducing a molecule into the cytosol of a cell in which the cell is contacted with a photosensitising agent, the cell is irradiated with light of a wavelength effective to activate the photosensitising agent and, substantially at the |
| 05/19/2004 | EP1420027A2 Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the NHE-inhibitory efficacy of compounds |
| 05/19/2004 | EP1420021A1 DNA Methyltransferase inhibitors |
| 05/19/2004 | EP1419803A2 Pharmaceutical composition for topical administration comprising an antiviral substance and a glucocorticoid |
| 05/19/2004 | EP1419784A2 Proteosome vaccines against toxins, allergy and cancer |
| 05/19/2004 | EP1419782A1 Use of consensus interferon for reducing the side-effects of interferon treatment in viral hepatitis |
| 05/19/2004 | EP1419777A1 Use of glycyrrhizin and its derivatives as MCP-1 production inhibitors |
| 05/19/2004 | EP1419393A1 Tumor specific oligosaccharide sequences and use thereof |
| 05/19/2004 | EP1419264A2 Kinases and phosphatases |
| 05/19/2004 | EP1419256A2 Conjugates for the modulation of immune responses |
| 05/19/2004 | EP1419175A2 Replikin peptides and uses thereof |
| 05/19/2004 | EP1419174A2 Process for preparing glycopeptide derivatives |
| 05/19/2004 | EP1419158A1 Pteridinone derivatives as modulators of chemokine receptor activity |
| 05/19/2004 | EP1419155A2 Piperidine derivatives as antibacterial agents |
| 05/19/2004 | EP1419152A1 Hiv inhibiting pyrimidines derivatives |
| 05/19/2004 | EP1419150A2 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 05/19/2004 | EP1419119A1 Water-insoluble, antimicrobial silicate glass and use thereof |
| 05/19/2004 | EP1419118A1 Antimicrobial, anti-inflammatory, wound-healing glass powder and use thereof |
| 05/19/2004 | EP1418942A2 Poxvirus-containing compositions and process for their preparation |
| 05/19/2004 | EP1418941A2 Vaccination against the feline immunodeficiency virus |
| 05/19/2004 | EP1418938A1 Bont/e or snap-25e for treating botulinum toxin a or c1 poisoning and inhibiting muscle contraction |
| 05/19/2004 | EP1418936A2 Pharmaceutical compositions for preventing or treating th1 and th2 cell related diseases by modulating the th1/th2 ratio. |
| 05/19/2004 | EP1418924A2 Single dose azithromycin for treating respiratory infections |
| 05/19/2004 | EP1418923A1 Anti-bacterial agents based upon oxoanion binding |
| 05/19/2004 | EP1418911A1 2,4,5-trisubstituted thiazolyl derivatives ant their antiinflammatory activity |
| 05/19/2004 | EP1418904A2 Tocopherol enriched compositions and amelioration of inflammatory symptoms |
| 05/19/2004 | EP1418889A2 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| 05/19/2004 | EP1418881A2 Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide |
| 05/19/2004 | EP1418880A1 Oral rinse for treatment or prevention of bacterial and fungal infection |
| 05/19/2004 | EP1418861A2 Methods for treating prostatitis |
| 05/19/2004 | EP1418814A2 Production of transduced hematopoietic progenitor cells |
| 05/19/2004 | EP1261357A4 Isolation and transplantation of retinal stem cells |
| 05/19/2004 | EP1235824B1 Vitamin d analogues |
| 05/19/2004 | EP1234024B1 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
| 05/19/2004 | EP1204416A4 Carnitine analogues as topical, microbicidal spermicides |
| 05/19/2004 | EP1190716B1 The leaves of cajanus cajan(l.) millsp and extract, formulation and uses thereof |
| 05/19/2004 | EP1163523B1 Method for detecting predisposition to a venous thromboembolic disease |
| 05/19/2004 | EP1041978A4 Methods of inactivating bacteria including bacterial spores |
| 05/19/2004 | EP1025102B1 Bicyclic kinase inhibitors |
| 05/19/2004 | EP1021553B1 Eukaryotic gene expression cassette and uses thereof |
| 05/19/2004 | EP1007551B1 Vaccine against hpv |
| 05/19/2004 | EP0832253B1 Nucleic acid respiratory syncytial virus vaccines |
| 05/19/2004 | EP0787190B1 Hepatitis e virus antigens and uses therefor |
| 05/19/2004 | DE60101056T2 Verfahren zur Herstellung von Ribavirin Process for the preparation of ribavirin |
| 05/19/2004 | DE10251914A1 New 2,3-diphenyl-quinazoline-4-acetic acid derivatives, useful as antiviral agents, especially effective against human cytomegalovirus infections |
| 05/19/2004 | CN1498225A Template-fixed peptidomimetics with antimicrobial activity |
| 05/19/2004 | CN1498224A Novel peptides as NS3-serine protease inhibitors of hepatitiscvirus |
| 05/19/2004 | CN1498221A Nucleoside derivatives as inhibitors of RNA-dependent PNA viral polymerase |
| 05/19/2004 | CN1498217A Heterocyclic compounds for aging-related and diabetic vascular complications |
| 05/19/2004 | CN1498212A New spirotricyclic derivatives and their use as phosphodiesterase-7-inhibitors |
| 05/19/2004 | CN1498211A Aniline derivative using as phosphodiesterase 4 inhibitor |
| 05/19/2004 | CN1498115A Hydroxyalkyl starch-active agent-conjugate |
| 05/19/2004 | CN1150206C Bradykinin antagonist peptides incorporating N-substituted glycines |
| 05/19/2004 | CN1150202C Nwe tylosin hydroxyl derivative and its producing process |
| 05/19/2004 | CN1150194C Carbocyclic nucleoside hemisufate and its use in treating viral infectiosn |
| 05/19/2004 | CN1150193C Crystal modification B of 8-cyano-1-cyclopropyl-7-(1S,6S-2,8-diaxabicyclo[4.3.o]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid |
| 05/19/2004 | CN1150192C Piperidines as CCR5 modulators |
| 05/19/2004 | CN1150186C 苯并咪唑化合物结晶 Benzimidazole compound crystallized |
| 05/19/2004 | CN1150031C Use of histamine of therapeutic purposes |
| 05/19/2004 | CN1150029C Methods for administration of antibiotics |
| 05/19/2004 | CN1150006C Beetoxin injection and its preparing process |
| 05/19/2004 | CN1150005C External medicine for treating tinea |
| 05/19/2004 | CN1149993C Pharmaceutical moxifloxacin preparation |
| 05/19/2004 | CN1149992C Antimycotic gel with active substance release |
| 05/19/2004 | CN1149978C Quinolone-containing liposome composition and their preparation method |
| 05/18/2004 | US6737522 Chicken interleukin-15 and uses thereof |
| 05/18/2004 | US6737441 Preventing or treating persistent chronic gastritis, ulcers and/or stomach cancer |
| 05/18/2004 | US6737440 2,5-bis ((alkyl (or aryl) imino) aminophenyl) furans, thiophenes or pyrroles |
| 05/18/2004 | US6737436 Pyrrole derivatives as phosphodiesterase VII inhibitors |
| 05/18/2004 | US6737429 Pyrrole derivatives |
| 05/18/2004 | US6737428 Respiratory syncytial virus |
| 05/18/2004 | US6737421 4-carboxyamido substituted; neurodegenerative diseases; neuronal damage |
| 05/18/2004 | US6737415 Anti-bacterial agents based upon oxoanion binding |
| 05/18/2004 | US6737403 Culturing microorganism streptomyces viridochromogenes, ssp. komabensis (atcc 29814) in culture medium, isolating laspartomycin, cleaving lipophilic fragment from laspartomycin, thereby yielding laspartomycin core peptide |
| 05/18/2004 | US6737267 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof |
| 05/18/2004 | US6737246 Incubating substance with a mixture comprising a protein, marker substrate, which binds to the catalytic domain and is converted by the protein, and substrate; determining whether the marker substrate is converted by the protein |
| 05/18/2004 | US6737233 Method for preparing HCV E2 binding protein |
| 05/18/2004 | US6737089 From the indian mulberry plant. |
| 05/18/2004 | US6737082 Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method |
| 05/18/2004 | US6737067 Composition comprising purified recombinant trimer of hiv gp160 which binds to cd4, binds to anti-gp120 antibody capable of neutralizing hiv infection of cells in vitro, binds to anti-gp41 antibody, and has no inter-chain disulfide bridges |
| 05/18/2004 | US6737063 Immunological polypeptides; vaccine against gramnegative bacteria |
| 05/18/2004 | US6737042 Delivery of drug esters through an inhalation route |
| 05/18/2004 | CA2334317C Antiviral pyrimidinedione derivatives and process for the preparation thereof |
| 05/13/2004 | WO2004039967A1 Immortalized natural killer cell line |
| 05/13/2004 | WO2004039833A1 Composition for the treatment of infection by flaviviridae viruses |
| 05/13/2004 | WO2004039829A2 Use of cpg oligonucleotides in the treatment of hepatitis c virus infection |
| 05/13/2004 | WO2004039823A1 Novel macrolide derivatives havaing effect of potentiating antifungal activity |
| 05/13/2004 | WO2004039822A2 4’’ - modified erythromycin derivatives |
| 05/13/2004 | WO2004039816A1 Crystal of inorganic acid salt of cephem compound |
| 05/13/2004 | WO2004039814A1 Cephem compounds |
| 05/13/2004 | WO2004039808A2 Process for the preparation of ganciclovir |
| 05/13/2004 | WO2004039806A1 Heterocyclic compounds |
| 05/13/2004 | WO2004039804A1 Amorphous moxifloxacin hydrochloride |
| 05/13/2004 | WO2004039803A2 Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use |
| 05/13/2004 | WO2004039797A1 A special kind of indole compounds, their preparation, and their use in treatment and prevention of those disease such as cancer |
| 05/13/2004 | WO2004039794A1 Cell activator, process for producing cell activator and appratus therefor |
| 05/13/2004 | WO2004039417A2 Drying process |
| 05/13/2004 | WO2004039399A1 Immunogenic composition |
| 05/13/2004 | WO2004039396A1 Drug containing angiotensin convertase |